JORDAN MAST: Open Payments
NPI 1518211051 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$88,190 in 510 payments from 44 companies in 2025. Trend: 2023 $24,643 · 2024 $60,449 · 2025 $88,190
Speaker / faculty: $43,055Consulting: $17,394Food & beverage: $12,476Honoraria: $6,000Travel & lodging: $5,195Speaker / faculty: $4,070
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 120 | $32,033 |
| Lilly USA, LLC | 52 | $22,959 |
| Eisai Inc. | 24 | $9,361 |
| PFIZER INC. | 43 | $8,885 |
| Axsome Therapeutics, Inc. | 25 | $8,118 |
| Lundbeck LLC | 16 | $841 |
| TG Therapeutics, Inc. | 12 | $415 |
| Alexion Pharmaceuticals, Inc. | 12 | $369 |
| Novartis Pharmaceuticals Corporation | 16 | $364 |
| Amgen Inc. | 5 | $346 |
Products named: KISUNLA, QULIPTA, Leqembi, NURTEC ODT, Symbravo, BOTOX, UBRELVY, VYEPTI.
Industry payments across CO — which companies pay providers there.
